Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH Agonist vs Progesterone for Luteal Support in FET
NCT06870266Phase 1Not yet recruiting
- Sponsor
- Shaare Zedek Medical Center
- Start
- Mar 2025
- Primary completion
- Mar 2027
- Modality
- Peptides, Small Molecules
01
Overview
Phase 1, randomised, open-label trial of nafarelin in infertility (2 arms), sponsored by Shaare Zedek Medical Center. Primary endpoint: Clinical Pregnancy Rate. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
nafarelin
03
Conditions
infertility
Beyond the preview
Go deeper on NCT06870266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06870266.